These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23892571)

  • 1. Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
    Moreno P; Mantey SA; Nuche-Berenguer B; Reitman ML; González N; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2013 Oct; 347(1):100-16. PubMed ID: 23892571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Nonpeptide Agonist MK-5046 Functions As an Allosteric Agonist for the Bombesin Receptor Subtype-3.
    Ramos-Alvarez I; Iordanskaia T; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 2022 Aug; 382(2):66-78. PubMed ID: 35644465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
    Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
    J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells.
    Sancho V; Moody TW; Mantey SA; Di Florio A; Uehara H; Coy DH; Jensen RT
    Peptides; 2010 Aug; 31(8):1569-78. PubMed ID: 20438784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
    Mantey SA; Coy DH; Entsuah LK; Jensen RT
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1161-70. PubMed ID: 15102928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3.
    Mantey SA; Coy DH; Pradhan TK; Igarashi H; Rizo IM; Shen L; Hou W; Hocart SJ; Jensen RT
    J Biol Chem; 2001 Mar; 276(12):9219-29. PubMed ID: 11112777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs.
    Uehara H; González N; Sancho V; Mantey SA; Nuche-Berenguer B; Pradhan T; Coy DH; Jensen RT
    Peptides; 2011 Aug; 32(8):1685-99. PubMed ID: 21729729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors.
    Mantey SA; Weber HC; Sainz E; Akeson M; Ryan RR; Pradhan TK; Searles RP; Spindel ER; Battey JF; Coy DH; Jensen RT
    J Biol Chem; 1997 Oct; 272(41):26062-71. PubMed ID: 9325344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
    Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of high affinity bombesin receptor subtype 3 agonists.
    Wu JM; Nitecki DE; Biancalana S; Feldman RI
    Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective human bombesin receptor subtype-3 peptide agonist mediates CREB phosphorylation and transactivation.
    Qin X; Qu X; Coy D; Weber HC
    J Mol Neurosci; 2012 Jan; 46(1):88-99. PubMed ID: 22127929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Characterization of a Novel, High-Affinity, Specific, Radiolabeled Ligand for BRS-3 Receptors.
    Ramos-Alvarez I; Lee L; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 2019 Jun; 369(3):454-465. PubMed ID: 30971479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.
    Gonzalez N; Hocart SJ; Portal-Nuñez S; Mantey SA; Nakagawa T; Zudaire E; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2008 Feb; 324(2):463-74. PubMed ID: 18006692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.
    Pradhan TK; Katsuno T; Taylor JE; Kim SH; Ryan RR; Mantey SA; Donohue PJ; Weber HC; Sainz E; Battey JF; Coy DH; Jensen RT
    Eur J Pharmacol; 1998 Feb; 343(2-3):275-87. PubMed ID: 9570477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells.
    Ryan RR; Weber HC; Mantey SA; Hou W; Hilburger ME; Pradhan TK; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 1998 Oct; 287(1):366-80. PubMed ID: 9765358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
    Weber D; Berger C; Heinrich T; Eickelmann P; Antel J; Kessler H
    J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of receptor and protein kinase C activation in the internalization of the gastrin-releasing peptide receptor.
    Williams BY; Dion SB; Schonbrunn A
    Mol Pharmacol; 1998 Nov; 54(5):889-98. PubMed ID: 9804624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R).
    Katsuno T; Pradhan TK; Ryan RR; Mantey SA; Hou W; Donohue PJ; Akeson MA; Spindel ER; Battey JF; Coy DH; Jensen RT
    Biochemistry; 1999 Jun; 38(22):7307-20. PubMed ID: 10353842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for high affinity and selectivity of peptide antagonist, Bantag-1, for the orphan BB3 receptor.
    Nakamura T; Ramos-Álvarez I; Iordanskaia T; Moreno P; Mantey SA; Jensen RT
    Biochem Pharmacol; 2016 Sep; 115():64-76. PubMed ID: 27346274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonist.
    Guan XM; Metzger JM; Yang L; Raustad KA; Wang SP; Spann SK; Kosinski JA; Yu H; Shearman LP; Faidley TD; Palyha O; Kan Y; Kelly TM; Sebhat I; Lin LS; Dragovic J; Lyons KA; Craw S; Nargund RP; Marsh DJ; Strack AM; Reitman ML
    J Pharmacol Exp Ther; 2011 Feb; 336(2):356-64. PubMed ID: 21036912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.